ES2115308T3 - Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis. - Google Patents

Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis.

Info

Publication number
ES2115308T3
ES2115308T3 ES95118629T ES95118629T ES2115308T3 ES 2115308 T3 ES2115308 T3 ES 2115308T3 ES 95118629 T ES95118629 T ES 95118629T ES 95118629 T ES95118629 T ES 95118629T ES 2115308 T3 ES2115308 T3 ES 2115308T3
Authority
ES
Spain
Prior art keywords
lactones
antioxidant
useful
atherosclerosis
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95118629T
Other languages
English (en)
Inventor
Goffredo Rosini
Claudia Baldazzi
Eleonora Romagnoli
Stefano Saguatti
Silvano Piani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfa Wasserman SpA
Original Assignee
Alfa Wasserman SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wasserman SpA filed Critical Alfa Wasserman SpA
Application granted granted Critical
Publication of ES2115308T3 publication Critical patent/ES2115308T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LACTONAS DE FORMULA Y SUS SALES FARMACOLOGICAMENTE ACEPTABLES DOTADAS CON PROPIEDADES ANTIOXIDANTES E HIPOLIPIDEMICAS Y QUE MUESTRAN LA CAPACIDAD DE PREVENIR Y/O RETARDAR LA MODIFICACION OXIDANTE DE LAS LIPOPROTEINAS MEDIANTE LA COMPETICION CON LA CADENA DE PROPAGACION DE PEROXIDACION POR MEDIO DE UN PURIFICADOR EFECTIVO DE LOS RADICALES PEROXILICOS. LOS DERIVADOS OBJETO DE LA PRESENTE INVENCION SON UTILES EN EL TRATAMIENTO DE LA ATEROSCLEROSIS Y DE MUCHAS PATOLOGIAS VASCULARES RELACIONADAS, COMO CARDIOPATIAS ISQUEMICAS (ANGINA DE PECHO E INFARTO DE MIOCARDIO), TROMBOSIS CEREBRAL Y ARTERIOPATIAS PERIFERICAS, YA QUE DEBIDO A LOS ALTOS NIVELES DE PLASMA DE LOS LIPIDOS Y A LAS MODIFICACIONES OXIDANTES DE LAS LIPOPROTEINAS DE BAJA DENSIDAD (LDL) REPRESENTAN SUCESOS CRUCIALES EN LA PATOGENESIS DE LA ATEROSCLEROSIS.
ES95118629T 1994-12-21 1995-11-27 Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis. Expired - Lifetime ES2115308T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Publications (1)

Publication Number Publication Date
ES2115308T3 true ES2115308T3 (es) 1998-06-16

Family

ID=11340165

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95118629T Expired - Lifetime ES2115308T3 (es) 1994-12-21 1995-11-27 Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis.

Country Status (9)

Country Link
US (1) US5608084A (es)
EP (1) EP0718295B1 (es)
JP (1) JP2820652B2 (es)
AT (1) ATE165354T1 (es)
DE (1) DE69502168T2 (es)
DK (1) DK0718295T3 (es)
ES (1) ES2115308T3 (es)
GR (1) GR3026702T3 (es)
IT (1) IT1274355B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680340B2 (en) * 2000-08-21 2004-01-20 Merck & Co., Inc. Anti-hypercholesterolemic drug combination
DE10261067A1 (de) * 2002-12-24 2004-08-05 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4665091A (en) * 1985-11-04 1987-05-12 Merck & Co., Inc. Macrocyclic lactone HMG-CoA reductase inhibitors
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
DE69502168T2 (de) 1998-08-13
GR3026702T3 (en) 1998-07-31
EP0718295B1 (en) 1998-04-22
ITBO940562A0 (it) 1994-12-21
EP0718295A1 (en) 1996-06-26
DE69502168D1 (de) 1998-05-28
DK0718295T3 (da) 1999-01-11
JPH08231535A (ja) 1996-09-10
IT1274355B (it) 1997-07-17
ATE165354T1 (de) 1998-05-15
ITBO940562A1 (it) 1996-06-21
JP2820652B2 (ja) 1998-11-05
US5608084A (en) 1997-03-04

Similar Documents

Publication Publication Date Title
Hoffman et al. Immersive virtual reality as an adjunctive non-opioid analgesic for pre-dominantly Latin American children with large severe burn wounds during burn wound cleaning in the intensive care unit: a pilot study
ES2162908T3 (es) Derivados de la proteina-1 quimioatractora de monocitos (mcp-1) humana.
ES467828A1 (es) Un procedimiento para preparar nuevos compuestos de cefem y cefam
ES2157422T3 (es) Trigliceridos y esteres etilicos de acido fenilalcanoico y acido fenilalquenoico utiles en el tratamiento de diversos trastornos.
MX9703621A (es) Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples.
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
UY26883A1 (es) Combinación terapéutica
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
ES2063011T3 (es) Agentes antibacteriales de quinolonas y naftiridinas que contienen un alfa-aminoacido en la cadena lateral del 7-sustituyente.
AR021481A1 (es) Compuestos de 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas, uso para la preparacion de medicamentos, composiciones y kit que lo contiene
ES2182888T3 (es) Inhibidores de la sintesis de los acidos grasos como agentes antimicrobianos.
FI971494A7 (fi) Eetterilipidiloposomit sekä niiden terapeuttinen käyttö
CY1105941T1 (el) ΡΕΤΙΝΟΕΙΔΙΚΟΙ ΑΓΩΝΙΣΤΕΣ ΕΚΛΕΚΤΙΚΟΙ ΩΣ ΠΡΟΣ RARγ ΓΙΑ ΤΗ ΘEPΑΠΕΙΑ ΤΟΥ ΕΜΦΥΣΗΜΑΤΟΣ
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
CR7785A (es) Compuestos de tiazol para el tratamiento de trastornos neurodegenerativos
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
CY1108748T1 (el) Χρηση αναστολεων της il-18 για την αντιμετωπιση και/η προληψη περιφερικων αγγειακων παθησεων
ATE433989T1 (de) Pharmazeutisch wirksame uridinester
EE200200625A (et) Orto-asendatud antraniilhappeamiidid ja nende kasutamine ravimitena
PA8525401A1 (es) Compuestos farmaceuticos
BR0013935A (pt) IsÈmeros oticamente ativos de cetotifeno e metabólitos terapeuticamente ativos dos mesmos
ES2253378T3 (es) Extractos de espermatofitos con actividad antineoplasica.
ES2166577T3 (es) Acidos 6- y 7-aminotetrahidroisoquinolin-carboxilicos sustituidos.
ES2151716T3 (es) Derivados peptidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 718295

Country of ref document: ES